EGFR and pancreatic neoplasm: AM251 (admittedly at higher concentrations) also upregulates the mRNA for both EGFR and its ligands in PANC-1 pancreatic cancer cells, which lack CB1 receptors [10], so effects (or the lack of them) at higher concentrations of the compound would be very difficult to interpret.